drugset
drugset / Trial / NCT04045548

Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery

NCT04045548 ↗

Phase 4 Completed 200 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces failed insertions, insertion-related complications, and pain in Women With no Previous Vaginal Delivery.

Timeline

Start
2019-08-10
Primary completion
2020-01-01
Completion
2020-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications

No indication recorded.